Xenon Pharmaceuticals adopts 2026 Equity Incentive Plan effective June 2, 2026
Xenon Pharmaceuticals Inc. established a new equity incentive plan to grant options, restricted shares, RSUs and other share-based awards to employees, officers, directors and consultants. The plan is designed to attract and retain talent while aligning employee interests with shareholder value creation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day